Barclays’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-566
| Closed | – | – | 5214 |
|
|
2021
Q1 | $0 | Buy |
+566
| New | +$401 | ﹤0.01% | 5371 |
|
|
2020
Q2 | – | Sell |
-27,669
| Closed | -$24K | – | 6498 |
|
|
2020
Q1 | $24K | Sell |
27,669
-56,065
| -67% | -$80.1K | ﹤0.01% | 5589 |
|
|
2019
Q4 | $137K | Buy |
83,734
+42,446
| +103% | +$63.7K | ﹤0.01% | 5289 |
|
|
2019
Q3 | $46K | Sell |
41,288
-26,388
| -39% | -$30.5K | ﹤0.01% | 5952 |
|
|
2019
Q2 | $83K | Buy |
67,676
+51,536
| +319% | +$65.6K | ﹤0.01% | 5828 |
|
|
2019
Q1 | $23K | Buy |
16,140
+12,140
| +304% | +$18K | ﹤0.01% | 6308 |
|
|
2018
Q4 | $5K | Sell |
4,000
-23,905
| -86% | -$35.5K | ﹤0.01% | 6484 |
|
|
2018
Q3 | $38K | Sell |
27,905
-5,020
| -15% | -$7.95K | ﹤0.01% | 6223 |
|
|
2018
Q2 | $75K | Buy |
32,925
+4,083
| +14% | +$7.89K | ﹤0.01% | 5426 |
|
|
2018
Q1 | $44K | Buy |
28,842
+18,430
| +177% | +$21.6K | ﹤0.01% | 5997 |
|
|
2017
Q4 | $7K | Buy |
10,412
+9,549
| +1,106% | +$8.54K | ﹤0.01% | 6613 |
|
|
2017
Q3 | $1K | Buy |
863
+743
| +619% | +$936 | ﹤0.01% | 6795 |
|
|
2017
Q2 | $0 | Sell |
120
-734
| -86% | -$1.56K | ﹤0.01% | 7082 |
|
|
2017
Q1 | $3K | Sell |
854
-476
| -36% | -$1.71K | ﹤0.01% | 6424 |
|
|
2016
Q4 | $6K | Buy |
1,330
+366
| +38% | +$1.21K | ﹤0.01% | 6106 |
|
|
2016
Q3 | $2K | Buy |
+964
| New | +$2.22K | ﹤0.01% | 6303 |
|
|
2016
Q2 | – | Sell |
-1,164
| Closed | -$2K | – | 6764 |
|
|
2016
Q1 | $2K | Buy |
1,164
+1,103
| +1,808% | +$2.5K | ﹤0.01% | 5908 |
|
|
2015
Q4 | $0 | Sell |
61
-131
| -68% | -$627 | ﹤0.01% | 6817 |
|
|
2015
Q3 | $1K | Sell |
192
-510
| -73% | -$3.46K | ﹤0.01% | 6664 |
|
|
2015
Q2 | $4K | Sell |
702
-3
| -0.4% | -$20 | ﹤0.01% | 6605 |
|
|
2015
Q1 | $5K | Buy |
+705
| New | +$5.32K | ﹤0.01% | 6620 |
|
Barclays's GEN Position: Q2 2021 in Review
Barclays sold out of Genesis Healthcare, Inc. (GEN) in Q2 2021, closing a stake of 566 shares.
Barclays first reported a position in GEN in Q1 2015 and held it in 21 quarters. The position peaked at $137K in Q4 2019. 1 fund tracked by Wall St. Rank holds GEN as of Q2 2021.
- Barclays reported no remaining Genesis Healthcare, Inc. position as of Q2 2021 after selling out during the quarter.
- Barclays sold 566 Genesis Healthcare, Inc. shares in Q2 2021.
- Barclays first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 21 quarters.
- Barclays's Genesis Healthcare, Inc. position peaked at $137K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2021.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.